戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 which was completely blocked by SKF 525A and miconazole.
2                                              Miconazole 10(-6) mol/L or 17-octadecynoic acid 10(-5) m
3                             Both 17-ODYA and miconazole (10(-5) mol/L, a chemically distinct P450 inh
4 zation, whereas clotrimazole (30 microM) and miconazole (15 microM) did not, and instead inhibited di
5 itories containing metronidazole 750 mg plus miconazole 200 mg or matching placebo for 5 consecutive
6 eived intravaginal metronidazole 750 mg plus miconazole 200 mg or placebo for 5 consecutive nights ea
7 ved intravaginal metronidazole (750 mg) plus miconazole (200 mg) or placebo for 5 consecutive nights
8 9.6+/-1.7% [control], 8.4+/-2.5% [0.96 mg/kg miconazole], 5.9+/-2.2% [0.28 mg/kg 17-ODYA], and 10.8+/
9                                 A once-daily miconazole 50 mg mucoadhesive buccal tablet (MBT) is a n
10                                              Miconazole, a nonselective inhibitor of cytochrome-P450
11 locked by ruthenium red, methanandamide, and miconazole, agents that inhibit the cation channel trans
12   Using measured volumes for nicardipine and miconazole aggregate particles (2.1 x 10(11) and 4.7 x 1
13 dazole, 1-phenylimidazole, clotrimazole, and miconazole all bound to the iNOSox monomer heme iron.
14                    We previously showed that miconazole, an inhibitor of CYP2E1, blocks defluorinatio
15 NF preferentially bound to the membrane, and miconazole and bromocriptine preferentially bound to the
16 300 microM, in the presence of indomethacin, miconazole and BW755c) and the stable analogue of arachi
17 sins bound cationic antifungal drugs such as miconazole and chlorhexidine digluconate (CG) through io
18                Mechanistic studies show that miconazole and clobetasol function in oligodendrocyte pr
19                                   Two drugs, miconazole and clobetasol, are effective in promoting pr
20  our results provide a rationale for testing miconazole and clobetasol, or structurally modified deri
21 t agreement between methods was observed for miconazole and clotrimazole and for C. krusei isolates t
22 ntifungal agents with the exceptions only of miconazole and clotrimazole and of terconazole against C
23                            When the data for miconazole and clotrimazole were removed from the analys
24 raconazole, and posaconazole) and topically (miconazole and clotrimazole) and by a tetrazole-based dr
25                     Clotrimazole, econazole, miconazole and CN- also significantly inhibited intracel
26                                Drugs such as miconazole and fenpropimorph that have different targets
27  However, equimolar intracerebellar doses of miconazole and forskolin (inhibitor and stimulator of ad
28 thanol's motor impairment by intracerebellar miconazole and forskolin, respectively.
29 1) to receive either a PICC impregnated with miconazole and rifampicin or a standard (non-antimicrobi
30  evidence of benefit or harm associated with miconazole and rifampicin-impregnated PICCs compared wit
31                                        While miconazole and sulconazole have intermediate activity ec
32 18F-FCWAY was almost completely inhibited by miconazole and, to a less extent, by diclofenac.
33 for TNS, 5.8 microm for ANF, 0.45 microm for miconazole, and 0.45 microm for bromocriptine.
34                 A nonspecific CYP inhibitor, miconazole, and 2 specific CYPomega-hydroxylase inhibito
35 or flucytosine, 77% for terconazole, 66% for miconazole, and 53% for clotrimazole.
36 onic acid (TNS), alpha-naphthoflavone (ANF), miconazole, and bromocriptine) binding to CYP3A4 incorpo
37 he four imidazoles (econazole, clotrimazole, miconazole, and ketoconazole) were active: 94.3 to 98.5%
38 e, ketoconazole, itraconazole, clotrimazole, miconazole, and terconazole) and compared the results wi
39 inhibitor, AA861, the epoxygenase inhibitor, miconazole, and the cyclooxygenase inhibitor, indomethac
40 eatment with the cyctochrome P450 inhibitor, miconazole, blocked the formation of these products.
41 d concentrations of triclosan, triclocarban, miconazole, carbamazepine, and diphenhydramine in plant
42 was somewhat resistant to agents (SKF 96365, miconazole, clotrimazole, nitrendipine, and trifluoperaz
43                              Three of these, miconazole, econazole, and sulconazole, were promiscuous
44                         Structurally related miconazole, econazole, and tioconazole bound with submic
45 w that low doses of amiodarone and an azole (miconazole, fluconazole) are strongly synergistic and ex
46             Immune response assays show that miconazole functions directly as a remyelinating drug wi
47 ncentrations of triclosan, triclocarban, and miconazole in root and shoot tissue by two to three orde
48 essels, however, were eliminated by PPOH and miconazole, inhibitors of CYP/epoxygenase.
49                  Cimetidine, diclofenac, and miconazole, known inhibitors of CYP450 2EI, were tested
50 fCYP51 focused attention on one primary hit, miconazole-like compound 2a.
51       The structurally unrelated EET ligands miconazole, MS-PPOH, and ketoconazole also inhibited the
52   In PET experiments, treatment of rats with miconazole nitrate (60 mg/kg intravenously) over the 45-
53 li, as well as effects of amphotericin-B and miconazole on S. cerevisiae through the device's time-de
54 eatment with intravaginal metronidazole plus miconazole reduced the proportion of visits with BV duri
55 ization, significant decreases were shown by miconazole-rifampicin (RR, 0.14 [95% CI, .05-.36]), 5-fl
56 The cytochrome P450 inhibitors, SKF 525A and miconazole, significantly attenuated these relaxations.
57                             18F-FCWAY PET in miconazole-treated rats can serve as an effective platfo
58                               The effects of miconazole treatment of rats on skull radioactivity upta
59                                              Miconazole treatment, by eliminating defluorination of 1
60 alf-life of radioligand was also extended by miconazole treatment.
61           ER stress generated in response to miconazole, tunicamycin, or other inhibitors also trigge
62  lanosterol, and the topical antifungal drug miconazole was the strongest inhibitor that we identifie
63 ytochrome P-450 inhibitors (clotrimazole and miconazole), we measured the carotid sinus nerve (CSN) d
64  that form large aggregates, nicardipine and miconazole, we measured particle numbers directly by flo
65  study, two commercial drugs, Loratadine and Miconazole, were identified as potential ligands for PFT
66 ant group of antifungals is the azoles (e.g. miconazole), which act by inhibiting lanosterol demethyl
67 le antimycotics, clotrimazole, econazole and miconazole, which are potent P450 inhibitors, significan
68                            CYP130 also binds miconazole with virtually the same binding affinity as e